[Hexobarbital-oxidation in vivo and in vitro in rats with bile duct ligation or ANIT-cholestasis (author's transl)]. 1977

D Brachtel, and H Gallenkamp, and E Richter

Pharmacokinetics of hexobarbital in rats is not influenced by ligature of the common bile duct or by ANIT-cholestasis. Additional in vitro experiments with isolated liver microsomes show only slight changes of hexobarbital metabolism.

UI MeSH Term Description Entries
D008026 Ligation Application of a ligature to tie a vessel or strangulate a part. Ligature,Ligations,Ligatures
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D003135 Common Bile Duct The largest bile duct. It is formed by the junction of the CYSTIC DUCT and the COMMON HEPATIC DUCT. Choledochus,Bile Duct, Common,Common Bile Ducts,Duct, Common Bile
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006591 Hexobarbital A barbiturate that is effective as a hypnotic and sedative. Evipan,Hexenal,Hexobarbitone,Sodium Hexobarbital,Hexobarbital, Sodium
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013861 Thiocyanates Organic derivatives of thiocyanic acid which contain the general formula R-SCN. Rhodanate,Rhodanates

Related Publications

D Brachtel, and H Gallenkamp, and E Richter
June 1977, The Journal of pharmacology and experimental therapeutics,
D Brachtel, and H Gallenkamp, and E Richter
January 2014, Advanced biomedical research,
D Brachtel, and H Gallenkamp, and E Richter
October 2012, Neuroscience letters,
D Brachtel, and H Gallenkamp, and E Richter
January 2018, Ultrastructural pathology,
D Brachtel, and H Gallenkamp, and E Richter
August 1980, Leber, Magen, Darm,
D Brachtel, and H Gallenkamp, and E Richter
August 1980, Leber, Magen, Darm,
D Brachtel, and H Gallenkamp, and E Richter
August 1976, Casopis lekaru ceskych,
D Brachtel, and H Gallenkamp, and E Richter
April 1977, Casopis lekaru ceskych,
Copied contents to your clipboard!